290 related articles for article (PubMed ID: 22826391)
1. Pancreatic imaging mimics: part 2, pancreatic neuroendocrine tumors and their mimics.
Raman SP; Hruban RH; Cameron JL; Wolfgang CL; Fishman EK
AJR Am J Roentgenol; 2012 Aug; 199(2):309-18. PubMed ID: 22826391
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic neuroendocrine tumor: review of heterogeneous spectrum of CT appearance.
Lee NJ; Hruban RH; Fishman EK
Abdom Radiol (NY); 2018 Nov; 43(11):3025-3034. PubMed ID: 29594467
[TBL] [Abstract][Full Text] [Related]
3. Vascular pancreatic lesions: spectrum of imaging findings of malignant masses and mimics with pathologic correlation.
Bhosale PR; Menias CO; Balachandran A; Tamm EP; Charnsangavej C; Francis IR; Elsayes KM
Abdom Imaging; 2013 Aug; 38(4):802-17. PubMed ID: 22968429
[TBL] [Abstract][Full Text] [Related]
4. Mimics of pancreatic ductal adenocarcinoma.
Al-Hawary MM; Kaza RK; Azar SF; Ruma JA; Francis IR
Cancer Imaging; 2013 Sep; 13(3):342-9. PubMed ID: 24060833
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of duodenal gastrointestinal stromal tumors from hypervascular pancreatic neuroendocrine tumors in the pancreatic head using contrast-enhanced computed tomography.
Ren S; Chen X; Wang J; Zhao R; Song L; Li H; Wang Z
Abdom Radiol (NY); 2019 Mar; 44(3):867-876. PubMed ID: 30293109
[TBL] [Abstract][Full Text] [Related]
6. Small serotonin-producing neuroendocrine tumor of the pancreas associated with pancreatic duct obstruction.
Kawamoto S; Shi C; Hruban RH; Choti MA; Schulick RD; Fishman EK; Siegelman SS
AJR Am J Roentgenol; 2011 Sep; 197(3):W482-8. PubMed ID: 21862776
[TBL] [Abstract][Full Text] [Related]
7. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?
Toshima F; Inoue D; Komori T; Yoshida K; Yoneda N; Minami T; Matsui O; Ikeda H; Gabata T
Jpn J Radiol; 2017 May; 35(5):242-253. PubMed ID: 28258323
[TBL] [Abstract][Full Text] [Related]
8. Correlation of computed tomography imaging features and pathological features of 41 patients with pancreatic neuroendocrine tumors.
Utsumi M; Umeda Y; Takagi K; Takashi K; Nobuoka D; Yoshida R; Shinoura S; Sadamori H; Yagi T; Fujiwara T
Hepatogastroenterology; 2015; 62(138):441-6. PubMed ID: 25916078
[TBL] [Abstract][Full Text] [Related]
9. Rare pancreatic masses: a pictorial review of radiological concepts.
Bezerra ROF; Machado MC; Dos Santos Mota MM; Ezzedine TA; Siqueira LTB; Cerri GG
Clin Imaging; 2018; 50():314-323. PubMed ID: 29751204
[TBL] [Abstract][Full Text] [Related]
10. Multimodality Imaging of the Pancreatic Neuroendocrine Tumors.
Singh A; Hines JJ; Friedman B
Semin Ultrasound CT MR; 2019 Dec; 40(6):469-482. PubMed ID: 31806146
[TBL] [Abstract][Full Text] [Related]
11. Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.
Wang Y; Chen X; Wang J; Cui W; Wang C; Chen X; Wang Z
Acta Radiol; 2021 Feb; 62(2):190-197. PubMed ID: 32375515
[TBL] [Abstract][Full Text] [Related]
12. Hypervascular solid-appearing serous cystic neoplasms of the pancreas: Differential diagnosis with neuroendocrine tumours.
Park HS; Kim SY; Hong SM; Park SH; Lee SS; Byun JH; Kim JH; Kim HJ; Lee MG
Eur Radiol; 2016 May; 26(5):1348-58. PubMed ID: 26328927
[TBL] [Abstract][Full Text] [Related]
13. An Intrapancreatic accessory spleen presenting as a neuroendocrine tumor.
Cartanese C; Minardi M; Crocco A; Barile G; De Luca R; Lomonaco R; Rucci A; Ruggieri E; Simone M
Ann Ital Chir; 2020 Jan; 9():. PubMed ID: 32129180
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade.
Takumi K; Fukukura Y; Higashi M; Ideue J; Umanodan T; Hakamada H; Kanetsuki I; Yoshiura T
Eur J Radiol; 2015 Aug; 84(8):1436-1443. PubMed ID: 26022520
[TBL] [Abstract][Full Text] [Related]
15. Peripancreatic paraganglioma mimics pancreatic/gastrointestinal neuroendocrine tumor on fine needle aspiration: Report of two cases and review of the literature.
Zeng J; Simsir A; Oweity T; Hajdu C; Cohen S; Shi Y
Diagn Cytopathol; 2017 Oct; 45(10):947-952. PubMed ID: 28560856
[TBL] [Abstract][Full Text] [Related]
16. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
[TBL] [Abstract][Full Text] [Related]
17. Imaging of neuroendocrine tumors of the pancreas.
Fidler JL; Johnson CD
Int J Gastrointest Cancer; 2001; 30(1-2):73-85. PubMed ID: 12489582
[TBL] [Abstract][Full Text] [Related]
18. Enhancing pancreatic mass with normal serum CA19-9: key MDCT features to characterize pancreatic neuroendocrine tumours from its mimics.
Zhu L; Xue HD; Liu W; Wang X; Sui X; Wang Q; Zhang D; Li P; Jin ZY
Radiol Med; 2017 May; 122(5):337-344. PubMed ID: 28197876
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography.
Lin X; Xu L; Wu A; Guo C; Chen X; Wang Z
Acta Radiol; 2019 May; 60(5):553-560. PubMed ID: 30086651
[TBL] [Abstract][Full Text] [Related]
20. Imaging of neuroendocrine tumors of the pancreas.
Dromain C; Déandréis D; Scoazec JY; Goere D; Ducreux M; Baudin E; Tselikas L
Diagn Interv Imaging; 2016 Dec; 97(12):1241-1257. PubMed ID: 27876341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
